MARKET

CRMD

CRMD

Cormedix
NASDAQ
7.43
-0.26
-3.38%
After Hours: 7.50 +0.07 +0.94% 18:22 02/11 EST
OPEN
7.77
PREV CLOSE
7.69
HIGH
7.78
LOW
7.34
VOLUME
2.74M
TURNOVER
--
52 WEEK HIGH
17.43
52 WEEK LOW
5.60
MARKET CAP
585.40M
P/E (TTM)
3.619
1D
5D
1M
3M
1Y
5Y
1D
Cormedix: Rezzayo and DefenCath Prophylaxis Upside Underscores Buy Rating and $13 DCF-Based Target
TipRanks · 11h ago
Cormedix: Steady Near-Term Base with High-Impact Label Expansion Catalysts Justifying a Buy Rating
TipRanks · 12h ago
Analyst Expectations For Cormedix's Future
Benzinga · 15h ago
CorMedix Is Maintained at Buy by D. Boral Capital
Dow Jones · 16h ago
CorMedix Price Target Maintained With a $14.00/Share by D. Boral Capital
Dow Jones · 16h ago
Cormedix (CRMD) Receives a Buy from RBC Capital
TipRanks · 16h ago
D. Boral Capital Maintains Buy on Cormedix, Maintains $14 Price Target
Benzinga · 16h ago
Weekly Report: what happened at CRMD last week (0202-0206)?
Weekly Report · 2d ago
More
About CRMD
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.

Webull offers CorMedix Inc stock information, including NASDAQ: CRMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRMD stock methods without spending real money on the virtual paper trading platform.